RAVEL Trial; Remifentanil patient-controlled analgesia (RPCA) vs epidural analgesia (EA) during labour

Completed

• Conditions: Pain during labour; 10010273

• Registration Number: NL-OMON38234
• Lead Sponsor: eids Universitair Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 1136

Inclusion Criteria

Age >18 years
Labour between 32-42 weeks of gestation
ASA physical status I or II

Exclusion Criteria

Prior administration of regional of opioid analgesia
Drug allergy: history of hypersensitivity to opioid or local anesthetic
substances
Initial maternal SpO2 of less than 95%
Initial maternal temperature of 38C or higher.
Contra-indication for epidural analgesia

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>This study will assess in women with a request for pain relief during labour<br /><br>the cost-effectiveness of RPCA as first choice treatment compared to EA. We<br /><br>will look at the following outcomes: costs, pain relief scores<br /><br>(pain-appreciation</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Maternal and Neonatal Side effects of both strategies.</p><br>